Introduction
Leishmaniasis is a disease with a broad range of clinical presentations, caused by protozoan parasites from the Leishmania genus [1] . The World Health Organization (WHO) estimates approximately 0.7 to 1.2 million cutaneous and 0.2 to 0.4 million visceral leishmaniasis cases per year around the world [2] . More than 90 % of visceral leishmaniasis cases are reported in developing countries such as India, Bangladesh, Brazil, Sudan, etc. [2] . Furthermore, this parasitic disease has emerged as a serious infection in human immunodeficiency virus-infected individuals in its visceral form, accounting for nearly 50 % of total visceral leishmaniasis cases reported in Brazil between 2011 and 2013 [3] .
For many years, the treatments for leishmaniasis were performed through the use of pentavalent antimonial compounds. However, these compounds are often associated with serious side effects in the kidneys, heart, liver, and pancreas [4, 5] . An effective alternative is the use of amphotericin B (AMPH) and its derivatives for the treatment of various leishmaniasis forms, although they present a high level of toxicity, high cost, and low solubility and bioavailability [5, 6] .
Piperlongumine is an amide alkaloid found in Piperaceae species that shows a broad spectrum of biological properties, including antitumor and antiparasitic activities. Herein, the leishmanicidal effect of piperlongumine and its derivatives produced by a biomimetic model using metalloporphyrins was investigated. The results showed that IC 50 values of piperlongumine in promastigote forms of Leishmania infantum and Leishmania amazonensis were 7.9 and 3.3 µM, respectively.
The IC 50 value of piperlongumine in the intracellular amastigote form of L. amazonensis was 0.4 µM, with a selectivity index of 25. The piperlongumine biomimetic derivatives, Ma and Mb, also showed leishmanicidal effects. We also carried out an in vitro metabolic degradation study showing that Ma is the most stable piperlongumine derivative in rat liver microsome incubations. The results presented here indicate that piperlongumine is a potential leishmanicidal candidate and support the biomimetic approach for development of new antileishmanial derivatives.
Leishmanicidal Effects of Piperlongumine (Piplartine) and Its Putative Metabolites
This set of limitations governing current chemotherapies for the treatment of leishmaniasis demonstrates the demand for the discovery of cost-effective drugs. For that, natural products and analogues have offered a remarkable source of compounds in screening for potential antileishmanial drugs [7, 8] . Alkaloids derived from Lauraceae, Solanaceae, Piperaceae, and other angiosperm families are used in folk medicine for the successful management of other neglected diseases and infections [8, 9] . Previous works on Piper species revealed that some of their bioactive compounds present antileishmanial activity and may be further explored for the production of new antileishmanial drugs [10] . Piperlongumine (PPL), also called piplartine, is one of these bioactive compounds (▶ Fig. 1 A) . It is a natural piperidine alkaloid derivative found in Piper species, e.g., Piper longum L., Piper tuberculatum J. (de Jacq.), and Piper arborescens Roxb. PPL has shown a broad spectrum of biological activities [11] [12] [13] [14] , including several tumor cell lines with minimal to no impact in normal cells [14] . In addition, PPL has demonstrated promising activity towards parasite species that cause neglected tropical diseases [15] [16] [17] [18] . Its leishmanicidal activity has been reported in promastigote forms of Leishmania donovani (IC 50 of 7.5 µM) [18] and Leishmania amazonensis (IC 50 of 564.1 µM) [15] .
Considering this background, the synthesis and evaluation of biological activity of PPL analogues may assist in the development of new leishmanicidal drug candidates [19, 20] . In this sense, biomimetic technologies have assisted in structural diversification of both aromatic and aliphatic compounds through single-step reactions without the presence of protecting groups [21] . Synthetic metalloporphyrins and Jacobsen catalysts aim to mimic in vivo metabolism carried out mainly by oxidative enzymes such as cytochrome P450 (CYP450) [21, 22] .
In this context, the aim of the present work was to evaluate the leishmanicidal effect of PPL and its derivatives (Ma and Mb compounds; ▶ Fig. 1 B, C, respectively) produced by a biomimetic model using metalloporphyrins. We also evaluated the hepatic microsomal stability properties of Ma and Mb for their possible bioavailability.
Results and Discussion
Biomimetic models have been used in the pursuit of bioactive compounds for drug discovery based on structural diversification and increased product yields [21] . In this sense, Jacobsen and metalloporphyrin reactions were employed in an attempt to reproduce the PPL metabolites formed in human liver microsomes [23] . Among the reaction conditions evaluated, only the reactions carried out in MeOH and with iodosylbenzene (PhIO), as the oxidant, led to the production of new compounds ( Low-energy collision-induced dissociation (CID) MS/MS analyses were performed in order to determine the molecular structure of each compound. The ion m/z 350.1598 of Ma (Fig. 5S , Supporting Information) was fragmented to produce second-generation ions. The fragment at m/z 280 resulted from the cleavage of an olefinic bond between C3 and C4. The ion at m/z 252 corresponds to the cleavage between C5 and C6 bond. The fragment at m/z 221 is relative to the amide function cleavage (N-C bond). The ion at m/z 190 was associated with a methoxyl group loss in the cinnamic portion. Fig. 6S , Supporting Information). The ester function was confirmed by a long-range correlation observed between a methyl signal at δ H 3.74 ppm (s-H-3) (▶ Table 1 ) and a quaternary carbon associated with an ester functionʼs carbonyl at δ H 167.4 ppm, via HMBC experiment. Additionally, it is possible to assign alkene signals related to an α,β-unsaturated carbonyl system at δ Table 1 ). Table 2 ; Figs. 11S-15S, Supporting Information). It was observed that a methoxylation in the cinnamic carbonyl portion led to the elimination of the lactam ring and formation of a methyl ester. This proposed structure was confirmed by long-range correlation signals between the methoxyl group at δ H 3.81 ppm (H-16) and carbonylʼs quaternary carbon (H-7) at δ H 167.4 ppm and carbon α-carbonyl (H-8) at δ H 117 ppm (▶ Table 2 ; Figs. 11S-15S, Supporting Information). The remaining signals follow the phenolic portion profile as observed with PPL (▶ Table 2 ). The PPL in vitro hepatic metabolism of humans and rats has been described previously [23, 24] . Two hydroxylated metabolites were identified after incubation with rat liver microsomes [24] . Four metabolites derived from O-demethylation, epoxidation, and hydroxylation reactions of PPL with human liver microsomes were described [23] . However, for this work, the oxidation of PPL catalyzed by metalloporphyrin did not mimic the CYP450 reactions.
On the other hand, our previous works with microsome (CYP450) and biomimetic reactions (Jacobsen and metalloporphyrins) yielded similar results [25, 26] . An example is the hydroxylation at the 5-position of dihydroergotamine observed for both models (CYP450 -human and rat liver microsomes and metalloporphyrin) [25] . However, the major product observed in the biological system, 8′-OH-dihydroergotamine, was not identified in the biomimetic models. In other cases, biomimetic catalysis produces more metabolites than observed in in vivo conditions [26] .
Once the structures were determined, Ma, Mb, PPL, and AMPH, a positive control, were evaluated in promastigote forms of L. amazonensis and L. infantum (▶ Fig. 2 ). Both L. amazonensis and L. infantum were susceptible to the compounds, but with differences in their susceptibility rate. Our results also demonstrated a dose-dependent activity in L. infantum, with IC 50 values of 7.9, 167.0, 384.2, and 0.58 µM for PPL, Ma, Mb, and AMPH, respectively, after 26 h of treatment (▶ Fig. 2; Fig. 16S , Supporting Information). For L. amazonensis, similar conditions produced IC 50 values for PPL, Ma, Mb, and AMPH of 3.3, 275.8, 160.5, and 0.86 µM, respectively (▶ Fig. 2; Fig. 17S , Supporting Information). Among the tested compounds, PPL was the most effective in both strains. These results are in agreement with the reported IC 50 values for PPL in promastigotes of L. donovani [18] . On the other hand, a recent study showed an IC 50 value of 564.1 µM for PPL in promastigotes of L. amazonensis [15] . Different incubation conditions may prevent an adequate comparison between these studies.
In the current work, modifications in the PPL structure led to a decrease in antileishmanial activity. A previous study demonstrated that the electrophilicity of the C3-C4 olefin is important for PPL activity [27] . Furthermore, the lack of olefin at C8-C9 is related to the reduction of PPL activity [27] . It was previously observed that the opening of the lactam ring of PPL or the introduction of an oxygen atom caused a significant reduction in leishmanicidal activity [15] . These results demonstrate that the presence of the C3-C4 olefin is critical for PPL activity in Leishmania strains. PPL and its putative metabolites are also effective in intracellular amastigote forms of L. amazonensis (▶ Fig. 3) . PPL, Ma, and Mb reduced the infection index in a dose-dependent manner with IC 50 values of 0.4, 3.2, and 13.4 µM, respectively (▶ Table 3 ). The evaluation of toxicity in mammalian cells is essential to determine the safety of the compounds. In this regard, selectivity indexes were obtained for amastigote forms of L. amazonensis (> 10 for all tested compounds), demonstrating a low toxicity to mammalian cells [15, 28, 29] .
Although the mechanism of action of PPL has not been elucidated, studies performed in tumor cells demonstrated that the cell death can be mediated by an increase in the level of reactive oxygen species (ROS) [14, 30] . PPL and putative metabolites (Ma and Mb) can induce oxidative stress in leishmania-infected macrophages nevertheless, further investigations should be undertaken in order to address the leishmanicidal effect of these compounds [31, 32] .
The convenience of therapy and patient compliance are important goals for a successful new treatment for leishmaniasis. The Drug for Neglected Disease initiative (DNDi) established some targets for new candidates for leishmaniasis treatment. A safe oral drug with greater than 90 % efficacy for a 10-day treatment is crucial in the case of visceral leishmaniasis [33] . In this context, our previous study predicted favorable pharmacokinetic characteristics of PPL, exhibiting negligible hepatic first-pass metabolism and slow hepatic metabolism catalyzed mainly by CYP3A4 and CYP1A2 isoenzymes with production of four metabolites [23] . Metabolic stability is a key feature for selection of new therapeutic agents. In this sense, the in vitro metabolic stability of Ma and Mb was determined in order to predict the in vivo metabolic clearance. Examination of the metabolic stability of Ma and Mb employing rat liver microsomes (▶ Table 4 ) showed that Ma [half-life (t 1/2 ) 180 min] may have a more appropriate plasma exposure than Mb (t 1/2 30 min) in vivo.
PPL and its derivatives, Ma and Mb, obtained via the metalloporphyrin biomimetic model exhibited leishmanicidal effects in Leishmania promastigote and amastigote forms. Among all the compounds examined, PPL showed the highest antileishmanial activity in in vitro assays. These results, together with previous pharmacokinetic studies [23] , demonstrate the potential of PPL as a candidate for the chemotherapeutic treatment of leishmaniasis. In addition, these results support the development of novel bioactive PPL derivatives in Leishmania disease.
Material and Methods

Reagents and solvents
PPL was isolated from P. tuberculatum Jacq (Piperaceae) according to a published procedure [16] , and the purity studies were performed by Lychnoflora, demonstrating 99 % purity. The solvents acetonitrile (ACN), methanol (MeOH), dichloroethane (DCE), and dichloromethane (DCM) of HPLC grade were purchased from Panreac. Deuterated Chloroform (CDCl 3 ) was purchased from Sigma-Aldrich. Carbamazepine (purity ≥ 99 %), used as an internal standard in the metabolic stability assay, was purchased from Sig-▶ [34] , and the iodometric assay (purity~96 %) was employed in assessing its purity [35] . 
Oxidation reactions and isolation of biomimetic reaction products
The reactions were performed in an Eppendorf amber flask (2 mL) with mechanical stirring (Vibrax VXR agitator, IKA) at room temperature. The proportion of substrate : catalyst : oxidant used was 6 : 0.3 : 9 mM, respectively. The solvent (0.5 mL of ACN, MeOH, DCE, or DCM), oxidant (PhIO or m-CPBA) and ((S,S)-or (R,R)-Jacobsen catalyst or [Fe(TCPP)Cl] were evaluated in a total of 24 experiments (Table 1S , Supporting Information). The reactions were stopped after 20 h and analyzed by HPLC (same conditions described in the "Metabolic stability" section). No products were detected in the control reactions carried out in the absence of a catalyst and under the same conditions as catalytic runs. The reaction selected for isolation of the metabolites in a semipreparative scale was composed of PPL: [Fe(TCPP)Cl]: PhIO in MeOH (0.5 mL). Fifty identical reactions were performed and the products were isolated using a Shimadzu HPLC system comprised of an SCL-10A VP system controller and SPD-M10A VP (190-800 nm) diode-array detector. The software used in the acquisition of the data was Class VP (Shimadzu). The C18 column was used for separation (250 mm × 20 mm, 10 µm, including a C18 guard column, 10 mm, 5 µm; Phenomenex). An isocratic elution composed of ACN : H 2 O (50 : 50, v/v) with a flow rate of 9 mL/min was employed and 1 mL of sample was injected. Ma and Mb were collected separately in flasks of 50 mL and dried using a lyophilizer from Liobras.
Identification of biomimetic reaction products
The isolated BRPs were analyzed in a mass spectrometer HRESI-MS (ultrOTOF-Q, Bruker Daltonics) operating in the positive mode. The sample was dissolved in ACN : H 2 O (1:1, v/v) and infused into the ESI source using a syringe pump at 300 µL/min. The acquisition was done using a capillary voltage of 3.0 kV, gas flow of 4 L/min, and desolvation temperature of 180°C. The drying, nebulizing, and collision gas used was nitrogen. Accurate masses were obtained using TFA-Na + 10 mg/mL (sodiated trifluoroacetic acid) as a calibrator agent. For structural elucidation, the isolated compounds were dissolved in CDCl 3 and analyzed in resonance nuclear equipment at 600 MHz (14.1 T magnetic field). 1 H, 1 H-13 C HSQC, and 1 H- 13 C HMBC experiments and elucidation proposals were based on the PPL standard. 
Animals and parasite cultures
Promastigote assay
Log phase promastigotes (2.5 × 10 6 cells/well) were aliquoted in Schneider medium (100 µL/well) into 96-well plates containing each compound diluted in the same medium (100 µL/well). The DMSO concentration in the wells was less than 1 %, and the final concentrations in each well of the tested compounds were PPL (0.2-25 µM), Ma and Mb (37.5-400 µM), and AMPH (0.015-2.0 µM). The plates were incubated for 20 h at 24°C, 5 % CO 2 . Alamar Blue (22 µL) was added to each well and the promastigotes were incubated under the same conditions for an additional 6 h. 
Antiamastigote assay
An intraperitoneal injection of 1.5 mL sterile 3 % thioglycolate medium was administered in BALB/c mice and peritoneal macrophages were harvested by peritoneal lavage after 96 h using cold RPMI 1640 medium supplemented with 10 % fetal bovine serum, 1 % L-glutamine, 10 UI/mL penicillin, and 10 µg/mL streptomycin.
▶ 
Macrophages in vitro cytotoxic assay
Mouse macrophages were obtained as described in the previous section and incubated in complete RPMI 1640 media containing 10 % fetal bovine serum, 1 % L-glutamine, 10 UI/mL penicillin, and 10 µg/mL streptomycin in 96-well plates at 37°C and 5 % CO 2 . The cells were washed with PBS after 24 h, and PPL (1.56-12.5 µM) and Ma and Mb (6.25-50 µM) were diluted in RPMI 1640 medium with DMSO, and added to the cell culture for 48 h at 5 % CO 2 and 37°C. The used DMSO concentration was less than 0.1 %. MTT solution (0.5 mg/mL; 100 µL/well) was added to the cells after the treatment periods and incubated for 4 h at 37°C. The supernatant was discarded, and the reaction product was diluted in DMSO. The wells absorbance was read using a SpectraMax microplate reader (Spectramax Plus, Molecular Devices) at 570 nm. All experiments were performed in triplicate on biological duplicates, and the percentage of viable cells was calculated in relation to the untreated control. The 50 % cytotoxicity concentration (CC 50 ) was determined by logarithm regression analysis of the data using GraphPad Prism 5.0 software.
Selectivity index
For calculation of the selectivity index, the ratio of the murine peritoneal macrophages CC 50 to the L. amazonensis intracellular amastigotes IC 50 was used.
Statistical analysis
IC 50 values were calculated according to a nonlinear regression using GraphPad Prism 5.0 software from two independent experiments performed in triplicate. The data were analyzed using oneway ANOVA employing GraphPad Prism 5.0. P values of less than 0.05 were used as a cutoff for calculating significance.
Metabolic stability
Hepatic metabolism of Ma and Mb was evaluated using pooled rat liver microsomes prepared as described previously [24] . The microsomal t 1/2 values were measured by monitoring substrate disappearance over time. Briefly, substrate stock solutions were prepared in DMSO and were used at 1 % (v/v) final working concentrations. Incubation mixtures (200 µL) were comprised of substrate (~5 µM), rat liver microsomes (1 mg/mL), and phosphate buffer (100 mM, pH 7.4). After 5 min pre-equilibration at 37°C, reactions were initiated by adding the NADPH cofactor (0.25 mM NADP+, 5 mM glucose-6-phosphate, and 0.5 U/mL glucose-6-phosphate dehydrogenase). The reaction mixtures were removed at 0, 5, 10, 20, 30, and 50 min and individually mixed with 200 µL of icecold acetonitrile containing the internal standard carbamazepine 210 µM (final concentration). The mixtures were vortexed for 20 s and centrifuged for 5 min at 2860 × g. The supernatant was removed, and aliquots were injected into the chromatographic system. A Shimadzu HPLC system composed of an LC-20AT solvent pump unit, a CTO-20A column oven, a DGU-20A5 online degasser, a CBM-20A system controller, and an SPD-30A (190-800 nm) diode-array detector was used to detect the metabolites (Ma and Mb). Injections were accomplished automatically using a 50-µL loop SIL-10AF. The data were collected using the LC solution software SPD-30A PDA utility (Shimadzu). The resolution of Ma and Mb was accomplished at 32°C on a Shimpack VP-ODS column acquired from Shimadzu (250 × 4.6 mm, 4.6 µm, particle size). 
Supporting information
Biomimetic reaction conditions tested, HPLC chromatograms in analytical and semipreparative scales for the reaction selected, MS and NMR spectra of Ma and Mb, and IC 50 s of AMPH in L. amazonensis and L. infantum promastigotes are available as Supporting Information.
